Skip to content
healthcare.dev

11 Tree Pollen Mix

NDC 22840-9482, Fagus grandifolia, Platanus occidentalis, Ulmus americana, Juglans nigra, Salix nigra, Populus deltoides, Quercus rubra, Betula nigra, Carya ovata, Acer saccharum and Fraxinus americana, solution, from Greer Laboratories, Inc..

Product NDC
22840-9482
Status
Listed
Labeler
Greer Laboratories, Inc.
Dosage form
SOLUTION
Route
INTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
Product type
NON-STANDARDIZED ALLERGENIC
Marketing category
BLA
Application
BLA101833
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/22840-9482 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ULMUS AMERICANA POLLEN1818.1818 [PNU]/mL
  • PLATANUS OCCIDENTALIS POLLEN1818.1818 [PNU]/mL
  • JUGLANS NIGRA POLLEN1818.1818 [PNU]/mL
  • SALIX NIGRA POLLEN1818.1818 [PNU]/mL
  • FAGUS GRANDIFOLIA POLLEN1818.1818 [PNU]/mL
  • POPULUS DELTOIDES POLLEN1818.1818 [PNU]/mL
  • ACER SACCHARUM POLLEN1818.1818 [PNU]/mL
  • QUERCUS RUBRA POLLEN1818.1818 [PNU]/mL
  • CARYA OVATA POLLEN1818.1818 [PNU]/mL
  • FRAXINUS AMERICANA POLLEN1818.1818 [PNU]/mL
  • BETULA NIGRA POLLEN1818.1818 [PNU]/mL

Pharmacologic classes

Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Non-Standardized Pollen Allergenic Extract [EPC]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]

Package NDCNDC-11Package
22840-9482-42284094820450 mL in 1 VIAL, MULTI-DOSE (22840-9482-4)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 22840-9482 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/22840-9482 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 22840-9482. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.